Title: Practice Area Director
Category: Managing Professional
Education: Ph.D., Biochemistry, B.S., Chemistry
Mike Krupp is focused on technology transfer and commercialization in life sciences. He works as a contributor to market research reports and with clients seeking assistance with licensing and technology transfer issues.
In addition to his activities with Foresight, he is a Business and Technology Adviser at the William J. von Liebig Center for Entrepreneurism and Technology advancement at the UC San Diego Jacobs School of Engineering, concentrating on the life sciences area. He also volunteers his time to the CONNECT Springboard program as an Entrepreneur in Residence to assist emerging life science companies prepare their business plans/strategy for presentation to funding organizations and is a member of the Board of the CONNECT Foundation.
Previously, Dr. Krupp was Senior Vice President of Business Development and the Chief Business Officer of Chugai Pharma USA, LLC (CPUSA) in San Diego, California. He was responsible for identifying and acquiring products and technology to complement and expand CPUSA’s project pipeline. Dr. Krupp led the market research and strategic marketing efforts for Chugai drug candidates outside of Japan, including the recently approved anti-IL-6 receptor antibody, Actemira - a novel agent for the treatment of rheumatoid arthritis. He was also responsible for general business operations for Chugai in the US. Prior to Chugai, Dr. Krupp served as Director, Licensing and Development, at Pfizer, Inc. He started his industry career in Pfizer Central Research in the areas of Diabetes Drug Discovery and General Pharmacology.
Dr. Krupp received his B.S. from Hobart College and his Ph.D. from the University of Rochester, School of Medicine. He completed Postdoctoral Research at The Johns Hopkins University School of Medicine.